Chlorpromazine in chronic schizophrenic women: Its effect on thyroid and liver function in relation to serum cholesterol concentration


In a controlled clinical trial, fifty-three chronic schizophrenic female subjects were treated with either chlorpromazine (N = 35) or placebo (N = 18). The mean serum cholesterol concentration increased by 8 mg per 100 ml in the chlorpromazine group while declining 30 mg per 100 ml in the placebo group. The adjusted mean difference in the analysis of… (More)
DOI: 10.1007/BF00404305


3 Figures and Tables